HIV 1/2 Ab Test
- UID
- MFG/IVD/2020/000021_d1ad8e75938caf0d7f4e1c262bd82563_ce44b8b4bfd3620c2955833d6c442a81
- Device class
- Class D
- Brand name
- PathoCatchTM
- License holder
- Mylab Discovery S0lutions Pvt. Ltd
- Approving authority
- Central Drug Standards Control Organization, West Zone
- Product information
- HIV 1/2 Ab Test is a rapid chromatographic immunoassay for the qualitative detection of antibodies specific to HIV-1 and HIV 2 in human serum, plasma or venous whole blood or capillary blood. The test is for in vitro diagnostic use and intended as an aid to diagnosis of HIV in symptomatic, asymptomatic populations and persons at risk of HIV infection. The test is not intended for use on neonates or infants below 2 years. The test is intended to be used by trained healthcare or laboratory professionals or other health care workers who have received appropriate training. The product is not for blood donor screening. More specific alternative diagnosis methods should be performed in order to obtain the confirmation of HIV Virus infection
HIV 1/2 Ab Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000021_d1ad8e75938caf0d7f4e1c262bd82563_ce44b8b4bfd3620c2955833d6c442a81. This device is marketed under the brand name PathoCatchTM. The license holder is Mylab Discovery S0lutions Pvt. Ltd, and it is classified as Device Class Class D. The approving authority is Central Drug Standards Control Organization, West Zone.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.